Tag: India
Helmut worked with USV Biologics since his time at Kwizda Pharma. Following his visit to our biologics manufacturing site in Mumbai, we continued to maintain the contact with him and finally hired him as a consultant for our biosimilar program. Subsequently, he accompanied our team with the goal to identify suitable Clinical Research Organizations in the United Kingdom, Germany, Hungary and Austria. In addition, Helmut significantly added business intelligence as to marketing strategies, pricing and regulatory processes of biosimilars in Europe. His management summaries are unsurpassed and with his competent consultancy advice, Helmut always delivered a reliable basis for USV’s management decisions regarding our biosimilar program. We can highly recommend Helmut as a consultant in the biosimilar field.
Dr. Esmail Samiwala, Senior Vice President, Biologics. USV Biologics, India
Late-stage vaccines and biosimilars operations
Technical and commercial operations mandates include roles at Bavarian Nordic to oversee late-stage vaccine programs for RSV and COVID-19. This role required guidance of cross-functional teams across Europe and the USA to execute a challenging development and launch strategy. The role also entailed commercial market aspects and an end-to-end strategy to safeguard a competitive advantage of the vaccines against established products. Similarly, a technical operations mandate at Intas Pharmaceuticals focused on guiding development and launch of the first European-approved Indian-made biosimilar. Responsibilities included management of CMC, supply chain, regulatory, pricing, partnering and out-licensing activities.